Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America BNP and NT-proBNP Market, by Location of Testing
1.4.2 North America BNP and NT-proBNP Market, by Application
1.4.3 North AMeirca BNP and NT-proBNP Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America BNP and NT-proBNP Market by Location of Testing
3.1 North America Point of Care Testing Market by Country
3.2 North America Laboratory Testing Market by Country
Chapter 4. North America BNP and NT-proBNP Market by Application
4.1 North America Myocardial Infarction Market by Country
4.2 North America Acute Coronary Syndrome (ACS) Market by Country
4.3 North America Congestive Heart Failure (CHF) Market by Country
4.4 North America Others Market by Country
Chapter 5. North America BNP and NT-proBNP Market by Country
5.1 US BNP and NT-proBNP Market
5.1.1 US BNP and NT-proBNP Market by Location of Testing
5.1.2 US BNP and NT-proBNP Market by Application
5.2 Canada BNP and NT-proBNP Market
5.2.1 Canada BNP and NT-proBNP Market by Location of Testing
5.2.2 Canada BNP and NT-proBNP Market by Application
5.3 Mexico BNP and NT-proBNP Market
5.3.1 Mexico BNP and NT-proBNP Market by Location of Testing
5.3.2 Mexico BNP and NT-proBNP Market by Application
5.4 Rest of North America BNP and NT-proBNP Market
5.4.1 Rest of North America BNP and NT-proBNP Market by Location of Testing
5.4.2 Rest of North America BNP and NT-proBNP Market by Application
Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.2 Siemens AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 SWOT Analysis
6.3 Danaher Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Gentian Diagnostics ASA
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.5 PerkinElmer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 BioMérieux S.A.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Quidel Corporation
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.8 Bio-Rad laboratories, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expenses
6.9 F. Hoffmann-La Roche Ltd. (Roche Holding Ltd.)
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.10. Scripps Laboratories
6.10.1 Company Overview
Unique Offerings 